Hepatobiliary elimination of the peroxisome proliferator nafenopin by conjugation and subsequent ATP-dependent transport across the canalicular membrane. 1994

G Jedlitschky, and I Leier, and M Böhme, and U Buchholz, and J Bar-Tana, and D Keppler
Division of Tumor Biochemistry, Deutsches Krebsforschungszentrum, Heidelberg, F.R.G.

Amphiphilic carboxylates acting as peroxisome proliferators and hypolipidemic drugs induce enzymes of peroxisomal lipid beta-oxidation, certain drug-metabolizing enzymes in the liver, and a number of additional proteins. The peroxisome proliferators represent a well-established class of non-genotoxic hepatocarcinogens. In this study we characterized the hepatic elimination of the peroxisome proliferator nafenopin. In the rat in vivo, 1 hr after intravenous administration of [3H]nafenopin, approx. 40% of injected radioactivity was recovered in bile. HPLC analysis of bile samples revealed that only about 10% of the radioactivity recovered in bile was associated with non-metabolized nafenopin and approx. 90% with more polar metabolites. One of the main metabolites formed in the liver and excreted into bile was identified as nafenopin glucuronide by beta-glucuronidase-catalysed reconversion to nafenopin. In mutant rats deficient in the canalicular transport of leukotriene C4 and related amphiphilic anion conjugates, recovery of [3H]nafenopin-derived radioactivity in bile was reduced to 4% of the injected dose. Although nafenopin glucuronide could not be detected in bile, it was a major metabolite in the liver from these mutant rats. Using membrane vesicles enriched in bile canalicular membranes from normal rats, transport of nafenopin glucuronide was shown to be a primary-active ATP-dependent process which was inhibited by leukotriene C4 and S-dinitrophenyl glutathione with IC50 values of 0.2 and 12 microM, respectively. ATP-dependent transport was not detectable for non-conjugated nafenopin. In canalicular membrane vesicles prepared from the mutant rats, the rate of ATP-dependent transport of nafenopin glucuronide was less than 10% of the transport observed in vesicles from normal rats. These data indicate that conjugation and subsequent transport by the ATP-dependent export carrier for leukotriene C4 and related conjugates is a major pathway for the elimination of nafenopin and structurally-related peroxisome proliferators.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009255 Nafenopin A peroxisome proliferator that is used experimentally to promote liver tumors. It has been used as an antihyperlipoproteinemic agent. CH-13437,Melipan,Nafenoic Acid,SU-13,437,Acid, Nafenoic,CH 13437,CH13437,SU 13,437,SU13,437
D005965 Glucuronates Derivatives of GLUCURONIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that include the 6-carboxy glucose structure. Glucosiduronates,Glucuronic Acids,Acids, Glucuronic
D000255 Adenosine Triphosphate An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter. ATP,Adenosine Triphosphate, Calcium Salt,Adenosine Triphosphate, Chromium Salt,Adenosine Triphosphate, Magnesium Salt,Adenosine Triphosphate, Manganese Salt,Adenylpyrophosphate,CaATP,CrATP,Manganese Adenosine Triphosphate,MgATP,MnATP,ATP-MgCl2,Adenosine Triphosphate, Chromium Ammonium Salt,Adenosine Triphosphate, Magnesium Chloride,Atriphos,Chromium Adenosine Triphosphate,Cr(H2O)4 ATP,Magnesium Adenosine Triphosphate,Striadyne,ATP MgCl2
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001646 Bile An emulsifying agent produced in the LIVER and secreted into the DUODENUM. Its composition includes BILE ACIDS AND SALTS; CHOLESTEROL; and ELECTROLYTES. It aids DIGESTION of fats in the duodenum. Biliary Sludge,Sludge, Biliary
D001648 Bile Canaliculi Minute intercellular channels that occur between liver cells and carry bile towards interlobar bile ducts. Also called bile capillaries. Bile Canaliculus,Canaliculi, Bile,Canaliculus, Bile
D001692 Biological Transport The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments. Transport, Biological,Biologic Transport,Transport, Biologic

Related Publications

G Jedlitschky, and I Leier, and M Böhme, and U Buchholz, and J Bar-Tana, and D Keppler
February 2001, Hepatology research : the official journal of the Japan Society of Hepatology,
G Jedlitschky, and I Leier, and M Böhme, and U Buchholz, and J Bar-Tana, and D Keppler
April 1994, FEBS letters,
G Jedlitschky, and I Leier, and M Böhme, and U Buchholz, and J Bar-Tana, and D Keppler
October 1991, Hepatology (Baltimore, Md.),
G Jedlitschky, and I Leier, and M Böhme, and U Buchholz, and J Bar-Tana, and D Keppler
October 1991, The Journal of biological chemistry,
G Jedlitschky, and I Leier, and M Böhme, and U Buchholz, and J Bar-Tana, and D Keppler
November 1990, The Journal of biological chemistry,
G Jedlitschky, and I Leier, and M Böhme, and U Buchholz, and J Bar-Tana, and D Keppler
April 1995, Physiological reviews,
G Jedlitschky, and I Leier, and M Böhme, and U Buchholz, and J Bar-Tana, and D Keppler
January 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
G Jedlitschky, and I Leier, and M Böhme, and U Buchholz, and J Bar-Tana, and D Keppler
April 1991, Biochemical and biophysical research communications,
G Jedlitschky, and I Leier, and M Böhme, and U Buchholz, and J Bar-Tana, and D Keppler
April 1998, The Biochemical journal,
G Jedlitschky, and I Leier, and M Böhme, and U Buchholz, and J Bar-Tana, and D Keppler
April 1991, Cancer research,
Copied contents to your clipboard!